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Objective. To develop a conceptual model for lung cancer rates to describe and quantify observed diﬀerences between Sweden and
USA contra Japan. Method. A two-parameter lognormal distribution was used to describe the lung cancer rates over time after a
1-year period of smoking. Based on that risk function in combination with smoking prevalence, the calculated age-standardized
rates were adjusted to ﬁt reported data from Japan, Sweden, and the USA by parameter variation. Results. The risk of lung cancer
is less in Japan than in Sweden and in the USA at the same smoking prevalence and intensity. Calculated age-speciﬁc rates did also
ﬁt well to reported rates without further parameter adjustments. Conclusions. This new type of cancer model appears to have high
degree of predictive value. It is recommended that data from more countries are studied to identify important life-style factors
related to lung cancer.
1.Introduction
Prior to 1955, the relationship between smoking tobacco
and lung cancer was not recognised as it is today. A 1955
Swedish encyclopaedia describes nervous problems, stomach
problems, and throat problems, but not lung cancer, as
possible results of heavy smoking [1]. However, after 1955,
lung cancer mortality began to suddenly increase in Sweden,
and older people in particular were subjected to a fast in-
creasing risk of lung cancer.
The aim of this study is to develop a conceptual model
forpredictinglungcancerrates.Suchmeansmaybeusefulin
promoting successful preventive work against lung cancer. In
cancerepidemiology,statisticalmodelsuselinearandlogistic
regression to evaluate relationships between risk factors and
cancer incidence. Less frequently used are biomathematical
models translating a hypothesis about the biological process
into mathematical terms [2].
There are diﬀerences between countries worldwide
regarding lung cancer even if they have similar cigarette con-
sumption per inhabitant and year [3]. This indicates that
there are other causative factors, as well as diﬀerent genetics,
still not considered or yet identiﬁed in epidemiological
studies of lung cancer.
The model developed for this study was based on a sim-
ilar model, successfully used for estimating melanoma rates
over time, taking reduced repair eﬃciency of sun-induced
skindamagesintoconsideration[4].Inthecurrentstudy,the
model developed for lung cancer had to account for varying
smoking prevalence over time.
The main ﬁnding from this study is that the model with
the parameters used was capable of predicting age-speciﬁc
incidence for both men and women in Sweden and for
men in the USA and Japan. The model study indicates that
the lung cancer risk after one year of smoking is larger in
Sweden and USA as compared to Japan. This conclusion was
strengthened by the fact that western countries in general
have twice the lung cancer rate as nonwestern countries at
equal cigarette consumption per person and year. A study of
associations between lung cancer rates and life-style factors
other than smoking is thus recommended.
2.MaterialsandMethods
Data on smoking prevalence were collected for men and
women from oﬃcial sources [5]. Age-speciﬁc smoking
prevalencedatahavebeenreportedinSwedensince1980and2 ISRN Oncology
Table 1: A life matrix based on annual smoking damage (N) and cancer risk (F) to get the accumulated risk over life time (vertical sum).
Year
Year Dmg Y1 Y2 Y3 Y4 Y5 Y6 Y7 ···
Y1 N1 N1F1 N1F2 N1F3 N1F4 N1F5 N1F6 N1F7 ···
Y2 N2 N2F1 N2F2 N2F3 N2F4 N2F5 N2F6 ···
Y3 N3 N3F1 N3F2 N3F3 N3F4 N3F5 ···
Y4 N4 N4F1 N4F2 N4F3 N4F4 ···
Y5 N5 N5F1 N5F2 N5F3 ···
Y6 N6 N6F1 N6F2 ···
Y7 N7 N7F1 ···
. . .
. . .
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
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
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Y7 ···
thetotalsmokingprevalencesince1916.Smokingprevalence
data from the USA and Japan were retrieved from [6, 7].
The expected life duration for smokers and non-smokers in
western countries were obtained from survival plots given by
Doll et al. [8].
This study sought to deﬁne a one-year period of average
smoking for men in Sweden as the basic damage-generating
unit causing a lung cancer risk that would increase by time
according to a statistical function. The smoking intensity per
lung volume among Swedish male smokers was deﬁned as
the norm in this model. The smoking intensities for men
in Japan and the USA and for women in Sweden were
adjusted to best ﬁt data and then compared with available
reported data. The probability function was used to calculate
cancer cases from each smoking period of one year over
the life time of a birth cohort consisting of 100,000 men
or women. The cancer cases from all these smoking periods
were then summed over time (calendar years) in a life
matrix (see Table 1) to give the primary calculated incidence.
This primary incidence versus age was ﬁnally adjusted for
Sweden and the USA to account for the reduced fraction of
smokers alive at old age due to the longer life expectancy of
nonsmokers in western countries [8].
This analysis was repeated for all birth cohorts to
calculate the age-standardized incidence over time. The
statistical functionsused werecharacterizedby twostatistical
parameters: the dispersion (in time, decades) and time to
reach 0.1% (used to deﬁne the median value) of a lognormal
distribution. The parameters were ﬁrst varied to identify the
best ﬁt of calculated age-standardized rates to reported rates
in Japan. To verify the usefulness of the model, calculated
age-speciﬁc incidences were compared with reported data
without further parameter variation. The dispersion giving
best ﬁt to reported rates in Japan was also used for Sweden
and the USA, while the time to 0.1% was further ﬁne-tuned
to ﬁt the Swedish and US data. We considered the dispersion
mainly to be a characteristic of the disease (lung cancer)
so that it should be used for all countries. The time to
0.1% risk of cancer is more likely to be a characteristic of
the environment and should thus be used as an adjustable
parameter to ﬁt data.
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Figure 1:AccumulatedlungcancerriskinSwedenandtheUSAand
in Japan from one year of smoking.
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Figure 2: Calculated and reported age-standardized incidence for
m e ni nJ a p a n .
3. Results
Figure 1 shows the basic lung cancer risks in Sweden and
the USA and in Japan from one year of smoking. Figure 2
shows age-standardized rates for men in Japan after varyingISRN Oncology 3
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Figure 3: (a) Calculated and reported age-standardized incidence
for women in Sweden using the same two parameters as were used
for Japan in Figure 2. (b) Calculated and reported age-standardized
incidence for women in Sweden after optimization of the parameter
value for time to 0.1%.
Table 2: Log-normal parameters for lung cancer risk functions.
Population Dispersion
(decades)
Time to 0.1%
(Years)
Japan male 0.30 45.13
Se male, Se female
USA male
0.30; 0.30
0.30
41.22; 41.00
41.43
the two parameters (dispersion and time to 0.1%) to best
ﬁt calculated and reported data. Figure 3(a) shows that the
calculated incidence for Swedish women would have been
a b o u tt w i c ea sl o wa sa c t u a l l yr e p o r t e d .I no r d e rt ob e t t e rﬁ t
reported data, the time to 0.1% had to be adjusted somewhat
which is shown in Figure 3(b) and in Table 2. The same
dispersion as for Japan was used also for men in Sweden and
in the USA and for women in Sweden.
We found the parameter values extracted from the
statistics on women very similar to parameters to ﬁt data
o nm e ni nS w e d e na n di nt h eU S A( F i g u r e s4 and 5).
Table 2 gives the parameters for best ﬁt to reported age-
standardised rates, used to calculate all incidences in Figures
2–9.Figure 6showsreportedandcalculatedage-speciﬁclung
cancer incidence for men in Japan. Similar results were
obtainedformeninSwedenandformenintheUSA(Figures
8 and 9). It is of interest to note that the rates for men and
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Figure 4: Calculated and reported age-standardized incidence for
men in Sweden after optimization of the parameter value for time
to 0.1%.
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Figure 5: Calculated and reported age-standardized incidence for
men in the USA after optimization of the parameter value for time
to 0.1%.
women older than 80 years since around 1995 have been
increasing (Figures 7 and 8). The sharp increase after 1997
for corresponding older men in Sweden cannot be explained
by the model, however.
A study of data from international cancer registries [9]i n
combination with reported cigarette consumption per capita
[10] showed that western countries have twice the amount
of lung cancer compared to nonwestern countries at similar
smoking levels (See Figure 10).
4. Discussion
We have here been using a mechanistic model requiring just
two parameters instead of the empirical methods normally
used, for example, in age-period cohort (APC) models [11,
12] .T h er a t e( R)a ta n ya g e( a)a n dp e r i o d( p)c a nb e
calculated as
Rap = exp

Aa + D ∗ p +Pp +Cc

,( 1 )
Here Aa is a constant that varies by age, D is a constant that
is multiplied by the period p, Pp is a speciﬁc constant added4 ISRN Oncology
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Figure 6: Calculated and reported age-speciﬁc lung cancer inci-
dence for men over time in Japan. Data are given for age groups
from 37 to 82 years, where R stands for reported data.
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Figure 7: Calculated and reported age-speciﬁc lung cancer inci-
dence for women over time in Sweden.
foreachperiod p,andC isaspeciﬁcconstantforeachcohort,
for example, birth cohort.
In order to generate the age-speciﬁc incidence plots and
age-standardised plots in Figures 2–9 using the APC model,
q u i t eal a r g en u m b e ro fp a r a m e t e r si sn e c e s s a r y .S u c ha
model of lung cancer mortality in relation to age, duration
of smoking, and daily cigarette consumption was studied by
Flanders et al. [13].
The connection between tobacco smoking and lung can-
cer has long been known (review in [14]). A comprehensive
reportontobaccouseandcancerwasgivenin[6].Inorderto
take diﬀerent smoking intensity patterns, deﬁned as number
of cigarettes per lung volume, between Sweden and USA
into consideration, we allowed an intensity factor to be
varied. Best ﬁt was found when the smoking intensity was
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Figure 8: Calculated and reported age-speciﬁc lung cancer inci-
dence for men over time in Sweden.
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Figure 9: Calculated and reported age-speciﬁc lung cancer inci-
dence for men over time in the USA.
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Figure 10: Lung cancer incidence versus cigarette consumption in
western and nonwestern countries.ISRN Oncology 5
Table 3: Smoking intensity relative to that of Swedish men.
Country, gender Smoking intensity relative to Swedish men
Sweden, men 1
Sweden, women 1, 14
Japan, men 1, 24
USA, men 3, 30
3.3 times larger in the USA as compared to Sweden. The
average annual weight of smoked tobacco per inhabitant
during the period from 1922 to 2002 was 1.047kg in Sweden
and3.318kgintheUSAor3.2timestheSwedishweight.The
computer also found a best ﬁt for Swedish women using a
smoking intensity of 1.19. Initially this was intriguing since
Swedish smoking women tend to smoke 12 cigarettes per day
compared with 15 for male smokers. However, taking their
diﬀerent lung volumes into consideration (4.2 vs. 6 litres), it
turned out that 12/4.2∗6/15 = 1.14, a value which was then
used for the calculations (Table 3).
We used information on life expectancy of smokers and
nonsmokers in western countries to correct the model for
decreasing ratios of smokers versus age among older people
in Sweden and in the USA. The generally observed decline
in cancer incidence for the oldest people was reviewed in
[15]. Due to natural death, there will be an accumulation of
survivors who have lived in good and healthy conditions and
this will manifest itself in lower cancer rates. This also makes
an argument to search for more speciﬁc information about
what these good conditions really are.
The question why the overall cancer risk is higher in
more developed countries was raised in [16]. One possi-
ble explanation was that the vulnerability has increased be-
cause the “immunity is aﬀected by factors associated with
economicprogressandawesternlife-style.”Suchfactorsmay
include diet, chemicals, or continuous exposure to immu-
ne-disturbing electromagnetic ﬁelds. Figure 10 shows lung
cancer rates versus smoking habits in western and nonwest-
ern countries.
Several studies report that there is a signiﬁcant reduction
in DNA repair capacity (DRC) found in lung cancer patients
compared with healthy controls, [17, 18]. There are rapid
methods for determination of DRC by blood tests to ﬁnd
candidates for intensive follow-up and possibly screening,
[19]. By using such methods, it is also possible not only
to compare lung cancer patients with healthy controls, but
also to compare DRC among healthy smokers from diﬀerent
populations, for example, from Japan and the USA. One step
in that direction was recently presented by Gandara et al.
[20].
Our ﬁndings from this model study indicate a signiﬁcant
diﬀerence between the capability of coping with heavy
smoking without getting lung cancer in Japan versus the
USA, and Sweden. If DRC generally is better in Japan than
in for example, the USA, then it is our ﬁrm belief that we
immediately should study what environmental factors that
might have the strongest inﬂuence on DRC and then use this
information for better cancer prevention strategies.
T h r e em a j o rc o n c l u s i o n sc a nb ed r a w nf r o mt h i ss t u d y .
(1) The aim of this study was to develop a conceptual
model for predicting lung cancer rates. Such a model
was indeed achieved and it will be an important
task to follow it over time as well as applying it to
statistical material from other countries.
(2) A study of associations between lung cancer rates,
DRC, and environmental and life-style factors other
than smoking is strongly recommended.
(3) Lung cancer rates in Sweden and the USA might
become signiﬁcantly reduced if we could identify and
adapt to such relevant factors in Japan.
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